European private medical insurers are seeing big savings when they vertically integrate or use intermediaries to ensure that patients see the right doctors.
The term integrated care can sometimes feel like an over-used buzzword. So it can help to think about what it means for the very patients who are most often failed by existing fragmented systems of care. For Jonathan Darer that means those with complex co-morbidities and how they are treated across the medical system from acute to their homes. Here we to talk to Dr.Darer, Medical Director, Siemens Healthineers and former chief innovation officer at Geisinger to explore why and what integrated care for such patients should look like and how to best deliver it. Few healthcare systems in the world are yet capable of delivering a continuity of care experience that is needed for these complex patients.
The CEO of the Netherlands’ largest ambulatory clinic has quickly scotched rumours of a sale, as he tells Healthcare Europa the group is looking to expand at home and abroad, move into a new field, and is planning a possible IPO.
Swiss start-up Corpus Health is launching a telemedicine platform in Switzerland in November, and is also eyeing Italy, partner Romain Boichat tells Healthcare Europa.
We talk to contacts in Finland about what the fast-approaching SOTE reforms will mean for a primary care market dominated by the public sector. Both agree that Finland is much better placed to see consolidation of the sector than Sweden when it underwent similar reforms several years ago.
Healthcare Nova speaks to Hari Buggana, chairman and managing director at India-focused investor InvAscent, about what makes a good investment, and why the Indian healthcare market is appealing at the moment.
French healthcare platform Doctegestio has been buying heavily in health and social care over the last few years, reaching a revenue run-rate of €240m which makes it a top 20 player in the country. We talk to its healthcare COO Benjamin Vitre about the thread holding a seemingly disparate group of healthcare assets together, and where he hopes the company will be in five years time.
Malaysia-based outpatient and corporate care group Qualitas’ planned IPO on the Singapore Exchange is “work in progress” and has been delayed to later this year, a well-placed source tells Healthcare Nova. HCN reported at the end of 2017 that Qualitas was planning to list on Singapore Exchange (SGX) to raise S$200m (US$152m) in early 2018. […]
Investors are starting to look closely at the Irish primary care and nursing home markets, we hear, for two reasons - one specific and one more general.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.